HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

CEV regimen

Subscribe to New Research on CEV regimen

chemotherapy regimen consisting of above cpds; used for treatment of small-cell lung cancer; do not confuse with CEV protocol which consists of cyclophosphamide, epirubicin & vincristine

Also Known As:

VEC regimen; VEJ regimen

Networked: 4 relevant articles (1 outcomes, 0 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 04/01/1996 - "A total of 9 patients with muscle-invasive bladder cancer (T3 or T4N0M0) were treated with a modified intra-arterial M-VEC (IA-M-VEC) regimen beginning in October 1992 to evaluate its therapeutic efficacy, and in 3 evaluable patients who subsequently underwent radical cystectomy, the possibility of bladder preservation was assessed. " Order ALL the reference details at left...
2.	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/01/1995 - "We compared the efficacy and toxicity of the CEV regimen (carboplatin at 300 mg/m2 on day 1, etoposide at 100 mg/body on days 1 to 3, and vincristine at 1 mg/m2 on days 1 and 8) with the PVP regimen (cisplatin at 80 mg/m2 on day 1 and etoposide at 100 mg/body on days 1 to 3) in patients with untreated small cell lung cancer (SCLC). " Order ALL the reference details at left...
3.	Vomiting 01/01/1990 - "The CEV regimen was not significantly more myelotoxic than EV but was associated with more severe nausea, vomiting and alopecia. " Order ALL the reference details at left...
4.	Thrombocytopenia (Thrombopenia) 08/01/1984 - "Dose limiting toxicity of the VEC regimen was leukopenia which occurred in most patients and thrombocytopenia was less frequent. " Order ALL the reference details at left...
5.	Nausea 01/01/1990 - "The CEV regimen was not significantly more myelotoxic than EV but was associated with more severe nausea, vomiting and alopecia. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Carboplatin (JM8)
2.	Vincristine (Oncovin)
3.	Etoposide (VP 16)
4.	Cisplatin (Platino)

Related Therapies and Procedures

1.	Cystectomy

blog comments powered by Disqus

TREATMENT OPTIONS
for Urinary Bladder Neoplasms,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 651 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$8.50 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$45.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>